Barchart.com
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Artiva Biotherapeutics Inc (ARTV)

Artiva Biotherapeutics Inc (ARTV)
3.40 x 1 5.90 x 1
Pre-market by (Cboe BZX)
4.04 -0.40 (-9.01%) 03/20/25 [NASDAQ]
3.40 x 1 5.90 x 1
Pre-market 3.50 -0.54 (-13.37%) 07:31 ET
News & Headlines for Thu, Mar 20th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference GlobeNewswire - Thu Feb 20, 3:05PM CST

ARTV : 4.04 (-9.01%)
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D. GlobeNewswire - Wed Jan 29, 3:05PM CST

ARTV : 4.04 (-9.01%)
Trader 2 at NYSE by Orhan Akkurt via Shutterstock
Stocks Set to Open Lower as Investors Trim Risk Amid Year-End Uncertainty Barchart - Mon Dec 30, 2024

March S&P 500 E-Mini futures (ESH25) are down -0.22%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.20% this morning, adding to Friday’s declines on Wall Street, as market participants reduced...

NFLX : 950.84 (-0.90%)
JWN : 24.31 (+0.08%)
NVDA : 118.53 (+0.86%)
LW : 52.75 (+0.13%)
AAL : 11.26 (-1.92%)
ARTV : 4.04 (-9.01%)
ESH25 : 5,637.75 (-0.44%)
BYW6.D.DX : 8.450 (-3.10%)
VIRX : 0.0250 (-5.66%)
TSLA : 236.26 (+0.17%)
NQH25 : 19,568.25 (-0.56%)
RCKT : 8.32 (-1.65%)
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy Zacks Investment Research - Fri Dec 6, 2024

Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its pipeline candidate, acimtamig (AFM13).The regulatory body granted the RMAT designation...

AFMD : 0.8970 (+1.34%)
CSTL : 20.07 (-2.29%)
SPRO : 0.7776 (+1.65%)
ARTV : 4.04 (-9.01%)
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights GlobeNewswire - Tue Nov 12, 2024

ARTV : 4.04 (-9.01%)
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference GlobeNewswire - Mon Nov 11, 2024

ARTV : 4.04 (-9.01%)
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors GlobeNewswire - Tue Oct 22, 2024

ARTV : 4.04 (-9.01%)
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment Motley Fool - Thu Aug 29, 2024

Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.

ARTV : 4.04 (-9.01%)

Barchart Exclusives

Globe Life for Steady Gains Barchart - 41 minutes ago
Summary Globe Life Inc. (GL) shows strong technical buy signals, with a Trend Seeker buy signal since 3/17 and a 0.77% gain. The company offers various life and supplemental health insurance products, with significant price appreciation and strong technical indicators. Analysts provide mixed ratings, with a midpoint price target of... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals
Wed, Mar 26, 2025 5:00 PM UTC
Reserve Your Spot